Keep informed of the latest developments in breast cancer and Pink-Link's latest news. Check back frequently to keep up to date.
If you have news to share and are a Pink-Link Member, Click Here.
If you are not a Pink-Link member, register here to become
a member - it's free!
Linking Breast Cancer Patients with Alternative Therapies
March 17, 2010 by Vicki Tashman, founder, Pink-Link
Biological-based therapies such as diet supplements and vitamins are the most popular complementary and alternative medicines (CAM) for women recovering from breast cancer, according to a
MichiganStateUniversity researcher working to create a support intervention for women in treatment for the disease.
Read More
2010 Young Survivor's Conference Summary
March 11, 2010 by Vicki Tashman, Founder of Pink-Link
The Young Survival Coalition's 10th Annual Conference was held in
Atlanta,
GA the weekend of February 26th. Pink-Link has exhibited at this conference for the last 5 years and this year was not a disappointment!
Read More
Acupuncture may be an Effective Therapy for Joint Pain and Stiffness
March 11, 2010 by Vicki Tashman, founder
A new study, led by researchers at the
HerbertIrvingComprehensiveCancerCenter at NewYork-Presbyterian Hospital/Columbia University Medical Center, demonstrates that acupuncture may be an effective therapy for joint pain and stiffness in breast cancer patients who are being treated with commonly used hormonal therapies. The results were published in the Journal of Clinical Oncology.
Read More
How does Estrogen fuel Cancer?
March 11, 2010 by Vicki Tashman, Founder
A new study is providing insight into how estrogen fuels many breast cancers, and researchers say the findings could lead to new cancer-fighting drugs.
Read More
Researchers Find Switch That Turns on the Spread of Cancer
February 20, 2010 by Vicki Tashman, founder
Reporting in the journal Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body.
Read More
Genes Linked to Breast Cancer Drug Resistance Could Guide Future Treatment Choices
January 31, 2010 by Vicki Tashman
Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.
Biological-based therapies such as diet supplements and vitamins are the most popular complementary and alternative medicines (CAM) for women recovering from breast cancer, according to a
The Young Survival Coalition's 10th Annual Conference was held in
A new study, led by researchers at the
A new study is providing insight into how estrogen fuels many breast cancers, and researchers say the findings could lead to new cancer-fighting drugs.
Reporting in the journal Nature Cell Biology, researchers describe the discovery of a specific protein called disabled-2 (Dab2) that switches on the process that releases cancer cells from the original tumor and allows the cells to spread and develop into new tumors in other parts of the body.
Researchers at Dana-Farber Cancer Institute have discovered a gene activity signature that predicts a high risk of cancer recurrence in certain breast tumors that have been treated with commonly used chemotherapy drugs.